Cargando…
Prognostic value of genomic mutations in metastatic prostate cancer()()
Metastatic prostate cancer (mPC) has a poor prognosis, and new treatment strategies are currently being offered for patients in clinical practice, but mPC is still incurable. A considerable proportion of patients with mPC harbor homologous recombination repair (HRR) mutations, which may be more sens...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9988500/ https://www.ncbi.nlm.nih.gov/pubmed/36895385 http://dx.doi.org/10.1016/j.heliyon.2023.e13827 |